Publication:
Imatinib mesylate reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukemia

Simple item page
dc.conference.dateDEC 05-08, 2015
dc.conference.locationOrlando, FL
dc.conference.organizer57th Annual Meeting of the American-Society-of-Hematology
dc.contributor.coauthorŞimşek, Eda Tanrıkulu
dc.contributor.coauthorEskazan, Ahmet Emre
dc.contributor.coauthorCengiz, Mahir
dc.contributor.coauthorAr, M. Cem
dc.contributor.coauthorEkizoğlu, Seda
dc.contributor.coauthorSalihoğlu, Ayşe
dc.contributor.coauthorGültürk, Emine
dc.contributor.coauthorElverdi, Tuğrul
dc.contributor.coauthorAydın, Seniz Öngören
dc.contributor.coauthorDemiröz, Ahu Senem
dc.contributor.coauthorBuyru, Ayşe Nur
dc.contributor.coauthorBaşlar, Zafer
dc.contributor.coauthorÖzbek, Uğur
dc.contributor.coauthorAydın, Yıldız
dc.contributor.coauthorTüzüner, Nükhet
dc.contributor.coauthorSoysal, Teoman
dc.contributor.departmentSchool of Medicine
dc.contributor.facultymemberYes
dc.contributor.kuauthorFerhanoğlu, Ahmet Burhan
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:05:02Z
dc.date.issued2015
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.openaccessNO
dc.description.peerreviewstatusN/A
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.studentonlypublicationNo
dc.description.studentpublicationNo
dc.description.versionN/A
dc.identifier.eissn1528-0020
dc.identifier.embargoN/A
dc.identifier.issn0006-4971
dc.identifier.quartileQ1
dc.identifier.urihttps://hdl.handle.net/20.500.14288/8743
dc.identifier.wos000368020102295
dc.keywordsLeukemia
dc.keywordsBCR-ABL positive
dc.keywordsBone marrow fibrosis
dc.keywordsImatinib mesylate
dc.language.isoeng
dc.publisherAmerican Society Hematology
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofBlood
dc.relation.openaccessN/A
dc.rightsN/A
dc.subjectHematology
dc.titleImatinib mesylate reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukemia
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.kuauthorFerhanoğlu, Ahmet Burhan
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Collections

Publications without Fulltext